MRPS5 and cardiac hypertrophy: Given that loss of Mrps5 resulted in cardiac hypertrophy and increased L-phenylalanine, we tested whether tetrahydrobiopterin (BH4) treatment could suppress hypertrophy in cardiomyocytes.